Robert Kirkman

2011 - Oncothyreon

In 2011, Robert Kirkman earned a total compensation of $1.1M as President, Chief Executive Officer and Director at Oncothyreon, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$192,035
Option Awards$484,000
Salary$398,000
Other$11,350
Total$1,085,385

Kirkman received $484K in option awards, accounting for 45% of the total pay in 2011.

Kirkman also received $192K in non-equity incentive plan, $398K in salary and $11.4K in other compensation.

Rankings

In 2011, Robert Kirkman's compensation ranked 5,363rd out of 10,747 executives tracked by ExecPay. In other words, Kirkman earned more than 50.1% of executives.

ClassificationRankingPercentile
All
5,363
out of 10,747
50th
Division
Services
803
out of 1,597
50th
Major group
Engineering, Accounting, Research, Management, And Related Services
66
out of 172
62nd
Industry group
Research, Development, And Testing Services
18
out of 45
60th
Industry
Commercial Physical and Biological Research
18
out of 41
56th
Source: SEC filing on April 24, 2014.

Kirkman's colleagues

We found five more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2011.

2011

Diana Hausman

Oncothyreon

Chief Medical Officer

2011

Gary Christianson

Oncothyreon

Chief Operating Officer

2011

Julia Eastland

Oncothyreon

Chief Financial Officer

2011

Scott Peterson

Oncothyreon

Chief Scientific Officer

2011

Christopher Henney

Oncothyreon

Chairman

You may also like